{"transactions":[{"id":1291603,"issuer":{"id":2498,"kind":"organization","name":"BECTON DICKINSON & CO","symbol":"BDX"},"owners":[{"id":83797,"kind":"person","name":"BURZIK CATHERINE M","position":1,"cik":"0001261141","reported_name":"BURZIK CATHERINE M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-30T21:05:26.000Z","date":"2025-01-28","kind":"grant","planned":false,"acquired":true,"shares":930,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes units acquired through dividend reinvestment since the last report filed by the reporting person."}],"balance_after":14264,"source":{"system":"sec-edgar","filing":"0001062993-25-001305","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/10795/000106299325001305/form4.xml","form_type":"4"}},{"id":1544879,"issuer":{"id":1975,"kind":"organization","name":"Orthofix Medical Inc.","symbol":"OFIX"},"owners":[{"id":83797,"kind":"person","name":"BURZIK CATHERINE M","position":1,"cik":"0001261141","reported_name":"BURZIK CATHERINE M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-04-09T20:54:46.000Z","date":"2024-04-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":47486,"price":14.23,"value":675725.78,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 32,763 previously reported deferred stock units."}],"balance_after":112803,"source":{"system":"sec-edgar","filing":"0000950170-24-043032","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/884624/000095017024043032/ownership.xml","form_type":"4"}},{"id":1671747,"issuer":{"id":2498,"kind":"organization","name":"BECTON DICKINSON & CO","symbol":"BDX"},"owners":[{"id":83797,"kind":"person","name":"BURZIK CATHERINE M","position":1,"cik":"0001261141","reported_name":"BURZIK CATHERINE M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-25T21:11:02.000Z","date":"2024-01-23","kind":"grant","planned":false,"acquired":true,"shares":900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes units acquired through dividend reinvestment since the last report filed by the reporting person."}],"balance_after":13242,"source":{"system":"sec-edgar","filing":"0001062993-24-001295","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/10795/000106299324001295/form4.xml","form_type":"4"}},{"id":1671746,"issuer":{"id":2498,"kind":"organization","name":"BECTON DICKINSON & CO","symbol":"BDX"},"owners":[{"id":83797,"kind":"person","name":"BURZIK CATHERINE M","position":1,"cik":"0001261141","reported_name":"BURZIK CATHERINE M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-25T21:08:51.000Z","date":"2019-01-22","kind":"grant","planned":false,"acquired":true,"shares":923,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This Form 4 is being amended to reflect the proper number of shares owned by the reporting person which incorrectly included shares previously gifted."}],"balance_after":8324,"source":{"system":"sec-edgar","filing":"0001062993-24-001292","document":"form4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/10795/000106299324001292/form4a.xml","form_type":"4/A","original_submission_date":"2019-01-24"}},{"id":1759316,"issuer":{"id":1975,"kind":"organization","name":"Orthofix Medical Inc.","symbol":"OFIX"},"owners":[{"id":83797,"kind":"person","name":"BURZIK CATHERINE M","position":1,"cik":"0001261141","reported_name":"BURZIK CATHERINE M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO"}}],"security":"Common Stock","published_at":"2023-10-17T21:14:24.000Z","date":"2023-10-15","kind":"grant","planned":false,"acquired":true,"shares":120676,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock units vest in full ninety (90) calendar days following the date that a successor Chief Executive Officer of Issuer assumes office following the Reporting Person's discontinuation of service as Interim Chief Executive Officer of Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 32,763 previously reported deferred stock units."}],"balance_after":158625,"source":{"system":"sec-edgar","filing":"0001209191-23-052978","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/884624/000120919123052978/doc4.xml","form_type":"4"}},{"id":1848295,"issuer":{"id":1975,"kind":"organization","name":"Orthofix Medical Inc.","symbol":"OFIX"},"owners":[{"id":83797,"kind":"person","name":"BURZIK CATHERINE M","position":1,"cik":"0001261141","reported_name":"BURZIK CATHERINE M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-21T20:18:37.000Z","date":"2023-06-19","kind":"grant","planned":false,"acquired":true,"shares":3589,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents an award of deferred stock units that vest in full on the earlier of (i) June 30, 2024 or (ii) the date on which the issuer holds its 2024 annual meeting of stockholders, subject to the reporting person's service through such date. Each deferred stock unit represents a contingent right to receive one share of common stock of the issuer. Vested deferred stock units will settle and convert into common stock within 45 days of the reporting person's termination of service with the issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 32,763 deferred stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 1,304 shares purchased by the reporting person, on April 30, 2023, under the Orthofix Medical Inc. Second Amended and Restated Stock Purchase Plan, in a transaction exempt under Rule 16b-3(c)."}],"balance_after":37949,"source":{"system":"sec-edgar","filing":"0001209191-23-038789","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/884624/000120919123038789/doc4.xml","form_type":"4"}},{"id":2025456,"issuer":{"id":1975,"kind":"organization","name":"Orthofix Medical Inc.","symbol":"OFIX"},"owners":[{"id":83797,"kind":"person","name":"BURZIK CATHERINE M","position":1,"cik":"0001261141","reported_name":"BURZIK CATHERINE M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-02-09T23:07:56.000Z","date":"2023-01-05","kind":"grant","acquired":true,"shares":14354,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Deferred stock unit award subject to deferred distribution after termination of service as a director of the Issuer, an exempt transaction, pursuant to Rule 16(b)-3(d) under the Securities Exchange Act of 1934, as amended. The award vests in full on the earlier of (i) June 30, 2024 or (ii) the date that the Company holds its 2024 annual meeting of stockholders."},{"field":"shares","element":"transactionShares","label":"F2","text":"This amendment is being made to correct the vesting date and the number of Deferred Stock Units awarded to the reporting person on January 5, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 29,174 deferred stock units."}],"balance_after":33056,"source":{"system":"sec-edgar","filing":"0001209191-23-008138","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/884624/000120919123008138/doc4a.xml","form_type":"4/A","original_submission_date":"2023-01-09"}},{"id":2046095,"issuer":{"id":2498,"kind":"organization","name":"BECTON DICKINSON & CO","symbol":"BDX"},"owners":[{"id":83797,"kind":"person","name":"BURZIK CATHERINE M","position":1,"cik":"0001261141","reported_name":"BURZIK CATHERINE M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-26T23:02:13.000Z","date":"2023-01-24","kind":"grant","acquired":true,"shares":848,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes units acquired through dividend reinvestment since the last report filed by the reporting person."}],"balance_after":13425,"source":{"system":"sec-edgar","filing":"0001062993-23-001429","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/10795/000106299323001429/form4.xml","form_type":"4"}},{"id":2059346,"issuer":{"id":1975,"kind":"organization","name":"Orthofix Medical Inc.","symbol":"OFIX"},"owners":[{"id":83797,"kind":"person","name":"BURZIK CATHERINE M","position":1,"cik":"0001261141","reported_name":"BURZIK CATHERINE M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-09T23:52:14.000Z","date":"2023-01-05","kind":"grant","acquired":true,"shares":14052,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Deferred stock unit award subject to deferred distribution after termination of service as a director of the Issuer, an exempt transaction, pursuant to Rule 16(b)-3(d) under the Securities Exchange Act of 1934, as amended. The award vests in full on the first anniversary of the grant date, January 5, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 28,872 deferred stock units."}],"balance_after":32754,"source":{"system":"sec-edgar","filing":"0001209191-23-002645","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/884624/000120919123002645/doc4.xml","form_type":"4"}},{"id":2192466,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":83797,"kind":"person","name":"BURZIK CATHERINE M","position":1,"cik":"0001261141","reported_name":"BURZIK CATHERINE M","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-08-08T21:20:22.000Z","date":"2022-08-05","kind":"grant","acquired":true,"shares":2730,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The securities awarded are in the form of restricted stock units (\"RSUs\") issued pursuant to the Haemonetics Corporation 2019 Long-Term Incentive Compensation Plan. The RSUs vest 100% on the first anniversary of the date of grant."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested."}],"balance_after":19545,"source":{"system":"sec-edgar","filing":"0001127602-22-020696","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760222020696/form4.xml","form_type":"4"}},{"id":2239559,"issuer":{"id":1975,"kind":"organization","name":"Orthofix Medical Inc.","symbol":"OFIX"},"owners":[{"id":83797,"kind":"person","name":"BURZIK CATHERINE M","position":1,"cik":"0001261141","reported_name":"BURZIK CATHERINE M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-08T20:35:15.000Z","date":"2022-06-06","kind":"grant","acquired":true,"shares":8844,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Deferred stock unit award subject to deferred distribution after termination of service as a director of the Issuer, an exempt transaction, pursuant to Rule 16(b)-3(d) under the Securities Exchange Act of 1934, as amended.  The award vest in full on the first anniversary of the grant date, June 6, 2022."}],"balance_after":17443,"source":{"system":"sec-edgar","filing":"0001209191-22-035049","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/884624/000120919122035049/doc4.xml","form_type":"4"}},{"id":2424784,"issuer":{"id":2498,"kind":"organization","name":"BECTON DICKINSON & CO","symbol":"BDX"},"owners":[{"id":83797,"kind":"person","name":"BURZIK CATHERINE M","position":1,"cik":"0001261141","reported_name":"BURZIK CATHERINE M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-27T13:37:44.000Z","date":"2022-01-25","kind":"grant","acquired":true,"shares":820,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes units acquired through dividend reinvestment since the last report filed by the reporting person."}],"balance_after":12499,"source":{"system":"sec-edgar","filing":"0001062993-22-001643","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/10795/000106299322001643/form4.xml","form_type":"4"}},{"id":2503685,"issuer":{"id":1975,"kind":"organization","name":"Orthofix Medical Inc.","symbol":"OFIX"},"owners":[{"id":83797,"kind":"person","name":"BURZIK CATHERINE M","position":1,"cik":"0001261141","reported_name":"BURZIK CATHERINE M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-19T21:04:37.000Z","date":"2021-11-19","kind":"purchase","acquired":true,"shares":1660,"price":30.27,"value":50248.2,"ownership":{"direct":true},"balance_after":7947,"source":{"system":"sec-edgar","filing":"0001209191-21-065776","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/884624/000120919121065776/doc4.xml","form_type":"4"}},{"id":2610956,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":83797,"kind":"person","name":"BURZIK CATHERINE M","position":1,"cik":"0001261141","reported_name":"BURZIK CATHERINE M","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-08-09T23:14:33.000Z","date":"2021-08-06","kind":"grant","acquired":true,"shares":3077,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The securities awarded are in the form of restricted stock units (\"RSUs\") issued pursuant to the Haemonetics Corporation 2019 Long-Term Incentive Compensation Plan. The RSUs vest 100% on the first anniversary of the date of grant."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested."}],"balance_after":16815,"source":{"system":"sec-edgar","filing":"0001127602-21-023391","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760221023391/form4.xml","form_type":"4"}},{"id":2657849,"issuer":{"id":1975,"kind":"organization","name":"Orthofix Medical Inc.","symbol":"OFIX"},"owners":[{"id":83797,"kind":"person","name":"BURZIK CATHERINE M","position":1,"cik":"0001261141","reported_name":"BURZIK CATHERINE M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-23T20:45:03.000Z","date":"2021-06-21","kind":"grant","acquired":true,"shares":21361,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These stock options vest in 25% increments on the first, second, third and fourth anniversaries of the grant date, June 21, 2021."}],"balance_after":21361,"derivative":{"exercise_price":40.58,"expiration_date":"2031-06-21","underlying":"Common Stock","underlying_shares":21361},"source":{"system":"sec-edgar","filing":"0001209191-21-042755","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/884624/000120919121042755/doc4.xml","form_type":"4"}},{"id":2657848,"issuer":{"id":1975,"kind":"organization","name":"Orthofix Medical Inc.","symbol":"OFIX"},"owners":[{"id":83797,"kind":"person","name":"BURZIK CATHERINE M","position":1,"cik":"0001261141","reported_name":"BURZIK CATHERINE M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-23T20:45:03.000Z","date":"2021-06-21","kind":"grant","acquired":true,"shares":5976,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Deferred Stock Unit award subject to deferred distribution after termination of service as a director of the Issuer, an exempt transaction pursuant to Rule 16b-3(d) under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"). The award vests in full on the first anniversary of the grant date, June 21, 2021."}],"balance_after":5976,"source":{"system":"sec-edgar","filing":"0001209191-21-042755","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/884624/000120919121042755/doc4.xml","form_type":"4"}},{"id":2893086,"issuer":{"id":2498,"kind":"organization","name":"BECTON DICKINSON & CO","symbol":"BDX"},"owners":[{"id":83797,"kind":"person","name":"BURZIK CATHERINE M","position":1,"cik":"0001261141","reported_name":"BURZIK CATHERINE M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-28T13:46:08.000Z","date":"2021-01-26","kind":"grant","acquired":true,"shares":829,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes units acquired through dividend reinvestment since the last report filed by the reporting person."}],"balance_after":11661,"source":{"system":"sec-edgar","filing":"0001543407-21-000005","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/10795/000154340721000005/edgar.xml","form_type":"4"}},{"id":3078426,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":83797,"kind":"person","name":"BURZIK CATHERINE M","position":1,"cik":"0001261141","reported_name":"BURZIK CATHERINE M","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-07-22T21:15:20.000Z","date":"2020-07-21","kind":"grant","acquired":true,"shares":1983,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The securities awarded are in the form of restricted stock units (\"RSUs\") issued pursuant to the Haemonetics Corporation 2019 Long-Term Incentive Compensation Plan. The RSUs vest 100% on the first anniversary of the date of grant."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This number includes unvested RSUs previously reported."}],"balance_after":13738,"source":{"system":"sec-edgar","filing":"0001127602-20-021975","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760220021975/form4.xml","form_type":"4"}},{"id":3298497,"issuer":{"id":2498,"kind":"organization","name":"BECTON DICKINSON & CO","symbol":"BDX"},"owners":[{"id":83797,"kind":"person","name":"BURZIK CATHERINE M","position":1,"cik":"0001261141","reported_name":"BURZIK CATHERINE M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-30T13:23:21.000Z","date":"2020-01-28","kind":"grant","acquired":true,"shares":765,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes units acquired through dividend reinvestment since the last report filed by the reporting person."}],"balance_after":10832,"source":{"system":"sec-edgar","filing":"0001543407-20-000012","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/10795/000154340720000012/edgar.xml","form_type":"4"}},{"id":3455668,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":83797,"kind":"person","name":"BURZIK CATHERINE M","position":1,"cik":"0001261141","reported_name":"BURZIK CATHERINE M","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-07-26T21:29:45.000Z","date":"2019-07-24","kind":"grant","acquired":true,"shares":1460,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The securities awarded are in the form of restricted stock units (\"RSUs\") issued pursuant to the Haemonetics Corporation 2005 Long-Term Incentive Compensation Plan (as amended). The RSUs vest 100% on the first anniversary of the date of grant."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested."}],"balance_after":11755,"source":{"system":"sec-edgar","filing":"0001127602-19-025263","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760219025263/form4.xml","form_type":"4"}},{"id":3508269,"issuer":{"id":2498,"kind":"organization","name":"BECTON DICKINSON & CO","symbol":"BDX"},"owners":[{"id":83797,"kind":"person","name":"BURZIK CATHERINE M","position":1,"cik":"0001261141","reported_name":"BURZIK CATHERINE M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-30T17:12:06.000Z","date":"2019-04-17","kind":"sale","acquired":false,"shares":45,"price":223.04,"value":10036.8,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes units acquired through dividend reinvestment since the last report filed by the reporting person."}],"balance_after":10007,"source":{"system":"sec-edgar","filing":"0001543407-19-000032","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/10795/000154340719000032/edgar.xml","form_type":"4"}},{"id":3508268,"issuer":{"id":2498,"kind":"organization","name":"BECTON DICKINSON & CO","symbol":"BDX"},"owners":[{"id":83797,"kind":"person","name":"BURZIK CATHERINE M","position":1,"cik":"0001261141","reported_name":"BURZIK CATHERINE M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-30T17:12:06.000Z","date":"2019-04-16","kind":"purchase","acquired":true,"shares":30,"price":247.96,"value":7438.8,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes units acquired through dividend reinvestment since the last report filed by the reporting person."}],"balance_after":10052,"source":{"system":"sec-edgar","filing":"0001543407-19-000032","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/10795/000154340719000032/edgar.xml","form_type":"4"}},{"id":3508267,"issuer":{"id":2498,"kind":"organization","name":"BECTON DICKINSON & CO","symbol":"BDX"},"owners":[{"id":83797,"kind":"person","name":"BURZIK CATHERINE M","position":1,"cik":"0001261141","reported_name":"BURZIK CATHERINE M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-30T17:12:06.000Z","date":"2018-06-22","kind":"purchase","acquired":true,"shares":45,"price":239.01,"value":10755.45,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes units acquired through dividend reinvestment since the last report filed by the reporting person."}],"balance_after":10022,"source":{"system":"sec-edgar","filing":"0001543407-19-000032","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/10795/000154340719000032/edgar.xml","form_type":"4"}},{"id":3508266,"issuer":{"id":2498,"kind":"organization","name":"BECTON DICKINSON & CO","symbol":"BDX"},"owners":[{"id":83797,"kind":"person","name":"BURZIK CATHERINE M","position":1,"cik":"0001261141","reported_name":"BURZIK CATHERINE M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-30T17:12:06.000Z","date":"2018-04-13","kind":"purchase","acquired":true,"shares":285,"price":225.89,"value":64378.65,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes units acquired through dividend reinvestment since the last report filed by the reporting person."}],"balance_after":9977,"source":{"system":"sec-edgar","filing":"0001543407-19-000032","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/10795/000154340719000032/edgar.xml","form_type":"4"}},{"id":3689007,"issuer":{"id":2498,"kind":"organization","name":"BECTON DICKINSON & CO","symbol":"BDX"},"owners":[{"id":83797,"kind":"person","name":"BURZIK CATHERINE M","position":1,"cik":"0001261141","reported_name":"BURZIK CATHERINE M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-01-24T15:40:29.000Z","date":"2019-01-22","kind":"grant","acquired":true,"shares":923,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes units acquired through dividend reinvestment since the last report filed by the reporting person."}],"balance_after":9692,"source":{"system":"sec-edgar","filing":"0001543407-19-000008","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/10795/000154340719000008/edgar.xml","form_type":"4"}},{"id":3859540,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":83797,"kind":"person","name":"BURZIK CATHERINE M","position":1,"cik":"0001261141","reported_name":"BURZIK CATHERINE M","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-07-30T22:06:01.000Z","date":"2018-07-26","kind":"grant","acquired":true,"shares":1696,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The securities awarded are in the form of restricted stock units (\"RSUs\") issued pursuant to the Haemonetics Corporation 2005 Long-Term Incentive Compensation Plan (as amended). The RSUs vest 100% on the first anniversary of the date of grant."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested."}],"balance_after":10295,"source":{"system":"sec-edgar","filing":"0001127602-18-024055","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760218024055/form4.xml","form_type":"4"}},{"id":4090688,"issuer":{"id":2498,"kind":"organization","name":"BECTON DICKINSON & CO","symbol":"BDX"},"owners":[{"id":83797,"kind":"person","name":"BURZIK CATHERINE M","position":1,"cik":"0001261141","reported_name":"BURZIK CATHERINE M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-01-25T17:13:58.000Z","date":"2018-01-23","kind":"grant","acquired":true,"shares":941,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes units acquired through dividend reinvestment since the last report filed by the reporting person."}],"balance_after":7259,"source":{"system":"sec-edgar","filing":"0001543407-18-000021","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/10795/000154340718000021/edgar.xml","form_type":"4"}},{"id":4248985,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":83797,"kind":"person","name":"BURZIK CATHERINE M","position":1,"cik":"0001261141","reported_name":"BURZIK CATHERINE M","relationship":{"director":true}}],"security":"Common Stock","published_at":"2017-07-31T22:21:10.000Z","date":"2017-07-27","kind":"grant","acquired":true,"shares":4329,"price":39.27,"value":169999.83,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted Stock Unit grant which vests 100% on the first anniversary of the grant date. Grant was made under 2005 Long Term Incentive Compensation Plan."}],"balance_after":8599,"source":{"system":"sec-edgar","filing":"0001127602-17-024409","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760217024409/form4.xml","form_type":"4"}},{"id":4481685,"issuer":{"id":2498,"kind":"organization","name":"BECTON DICKINSON & CO","symbol":"BDX"},"owners":[{"id":83797,"kind":"person","name":"BURZIK CATHERINE M","position":1,"cik":"0001261141","reported_name":"BURZIK CATHERINE M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-01-26T18:55:05.000Z","date":"2017-01-24","kind":"grant","acquired":true,"shares":1181,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes units acquired through dividend reinvestment since the last report filed by the reporting person."}],"balance_after":6318,"source":{"system":"sec-edgar","filing":"0001543407-17-000003","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/10795/000154340717000003/edgar.xml","form_type":"4"}},{"id":4573773,"issuer":{"id":3953,"kind":"organization","name":"HAEMONETICS CORP"},"owners":[{"id":83797,"kind":"person","name":"BURZIK CATHERINE M","position":1,"cik":"0001261141","reported_name":"BURZIK CATHERINE M","relationship":{"director":true}}],"security":"Common Stock","published_at":"2016-10-28T00:05:33.000Z","date":"2016-10-25","kind":"grant","acquired":true,"shares":4969,"price":34.21,"value":169989.49,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted Stock Unit Grant which vest 100% on the first anniversary of the grant date. Grant was made under 2005 Long Term Incentive Compensation Plan."}],"balance_after":4969,"source":{"system":"sec-edgar","filing":"0001127602-16-065437","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313143/000112760216065437/form4.xml","form_type":"4"}}]}